[HTML][HTML] Interstitial lung disease and pulmonary damage in primary sjögren's syndrome: a systematic review and meta-analysis

O Berardicurti, A Marino, I Genovali, L Navarini… - Journal of Clinical …, 2023 - mdpi.com
Background: Pulmonary lung involvement is the most common extra-glandular manifestation
in patients with primary Sjögren's syndrome (pSS), leading to a worsening of the patient's …

Sjögren syndrome: looking forward to the future

S Zandonella Callegher, I Giovannini… - Therapeutic …, 2022 - journals.sagepub.com
Primary Sjögren's syndrome (pSS) is a heterogeneous disease characterised by a wide
spectrum of manifestations that vary according to the different stages of the disease and …

A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and …

AG Tzioufas, AD Bakasis, AV Goules, K Bitzogli… - Journal of …, 2021 - Elsevier
Objectives To investigate humoral responses and safety of mRNA SARS-CoV-2 vaccines in
systemic autoimmune and autoinflammatory rheumatic disease (SAARD) patients subjected …

Clinical picture, outcome and predictive factors of lymphoma in primary Sjögren's syndrome: results from a harmonized dataset (1981–2021)

LG Chatzis, IE Stergiou, AV Goules, V Pezoulas… - …, 2022 - academic.oup.com
Abstract Objectives Primary Sjögren's Syndrome (pSS) carries the highest risk for non-
Hodgkin's lymphoma (NHL) development among systemic autoimmune diseases. However …

A biomarker for lymphoma development in Sjogren's syndrome: salivary gland focus score

L Chatzis, AV Goules, V Pezoulas, C Baldini… - Journal of …, 2021 - Elsevier
The aim of this study is to explore the role of labial minor salivary gland (LMSG) focus score
(FS) in stratifying Sjögren's Syndrome (SS) patients, lymphoma development prediction and …

[HTML][HTML] Addressing the clinical unmet needs in primary Sjögren's Syndrome through the sharing, harmonization and federated analysis of 21 European cohorts

VC Pezoulas, A Goules, F Kalatzis, L Chatzis… - Computational and …, 2022 - Elsevier
For many decades, the clinical unmet needs of primary Sjögren's Syndrome (pSS) have
been left unresolved due to the rareness of the disease and the complexity of the underlying …

Prevalence and comorbidities of Sjogren's syndrome patients in the Community of Madrid: A population-based cross-sectional study

J Barrio-Cortes, JA López-Rodríguez… - Joint Bone Spine, 2023 - Elsevier
Objectives To estimate the prevalence, sociodemographic characteristics and comorbidities
of Sjogren's syndrome (SS) patients in the Community of Madrid. Methods A population …

New frontiers in precision medicine for Sjogren's syndrome

L Chatzis, PG Vlachoyiannopoulos… - Expert review of …, 2021 - Taylor & Francis
Introduction: Sjögren's syndrome is a unique systemic autoimmune disease, placed in the
center of systemic autoimmunity and at the crossroads of autoimmunity and …

[HTML][HTML] Risk of cancer in connective tissue diseases in Northeastern Italy over 15 years

E Treppo, F Toffolutti, V Manfrè, M Taborelli… - Journal of clinical …, 2022 - mdpi.com
Objective: To evaluate cancer risk among individuals with connective tissue disease (CTD)
in Friuli Venezia Giulia, northern Italy. Methods: A population-based cohort study was …

[HTML][HTML] Regulation of MMP9 transcription by ETS1 in immortalized salivary gland epithelial cells of patients with salivary hypofunction and primary Sjögren's …

B Noll, FB Mougeot, MT Brennan, JLC Mougeot - Scientific Reports, 2022 - nature.com
Primary Sjögren's syndrome (pSS) patients exhibit enhanced degradation of the salivary
epithelium initially through MMP9 overexpression. We assessed the expression of MMP9 …